Kalyan Jewellers India announced strong financial results for the March quarter of FY26. Net profit more than doubled to Rs 409.5 crore. Revenue from operations surged 66.2% to Rs 10,274.9 crore. EBITDA also saw significant growth. The company recommended a final dividend of Rs 2.50 per equity share. International operations and the Candere platform also performed well.
Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check details
Wockhardt’s shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections. The drug, combining cefepime and zidebactam,